All Stories

  1. A select thiosemicarbazone copper(II) complex induces apoptosis in gastric cancer and targets cancer stem cells reducing pluripotency markers
  2. Trans-[Pt(amine)Cl2(PPh3)] Complexes Target Mitochondria and Endoplasmic Reticulum in Gastric Cancer Cells
  3. Platinum iodido drugs show potential anti-tumor activity, affecting cancer cell metabolism and inducing ROS and senescence in gastrointestinal cancer cells
  4. Proving the Antimicrobial Therapeutic Activity on a New Copper–Thiosemicarbazone Complex
  5. Tips and tops of chemical synthesis for Pt(II) complexes
  6. Dithiobiureas Palladium(II) complexes' studies: From their synthesis to their biological action
  7. Regulatory effects of miR-19a on MAD2 expression and tumorigenesis in gastric cancer
  8. Two novel Pd thiosemicarbazone complexes as efficient and selective antitumoral drugs
  9. Two Different Thiosemicarbazone Tauto‐Conformers Coordinate to Palladium (II). Stability and Biological Studies of the Final Complexes
  10. Chemical and Biological Evaluation of Thiosemicarbazone-Bearing Heterocyclic Metal Complexes
  11. Thiosemicarbazone Derivatives as Inhibitors of Amyloid-β Aggregation: Effect of Metal Coordination
  12. Exploring DNA binding ability of two novel α-N-heterocyclic thiosemicarbazone palladium(II) complexes
  13. New Platinum(II) Triazole Thiosemicarbazone Complexes: Analysis of Their Reactivity and Potential Antitumoral Action
  14. New Findings in the Signaling Pathways of cis and trans Platinum Iodido Complexes’ Interaction with DNA of Cancer Cells
  15. New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools
  16. Versatile Route to trans-Platinum(II) Complexes via Manipulation of a Coordinated 3-(Pyridin-3-yl)propanoic Acid Ligand
  17. Novel structures of platinum complexes bearing N‑bisphosphonates and study of their biological properties
  18. Four-component relativistic 31P NMR calculations for trans-platinum(ii) complexes: importance of the solvent and dynamics in spectral simulations
  19. Synthesis, Reactivity Studies, and Cytotoxicity of Two trans-Iodidoplatinum(II) Complexes. Does Photoactivation Work?
  20. Synthesis, Reactivity Studies and Cytotoxicity of Two Iodidoplatinum(II) Complexes. Does Photoactivation Work?
  21. XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells
  22. Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins
  23. Using phosphine ligands with a biological role to modulate reactivity in novel platinum complexes
  24. Mononuclear Pd(ii) and Pt(ii) complexes with an α-N-heterocyclic thiosemicarbazone: cytotoxicity, solution behaviour and interaction versus proven models from biological media
  25. Enhanced Cytotoxicity and Reactivity of a Novel Platinum(IV) Family with DNA-Targeting Naphthalimide Ligands
  26. Nonconventional trans‐Platinum Complexes Functionalized with RDG Peptides: Chemical and Cytototoxicity Studies
  27. Combining imaging and anticancer properties with new heterobimetallic Pt(ii)/M(i) (M = Re, 99mTc) complexes
  28. Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles
  29. Increasing DNA reactivity and in vitro antitumor activity of trans diiodido Pt(II) complexes with UVA light
  30. Synthesis, cytotoxicity, DNA interaction and cell cycle studies of trans-diiodophosphine Pt(ii) complexes
  31. cis-Pt I2(NH3)2: a reappraisal
  32. Design and Biological Evaluation of New Platinum(II) Complexes Bearing Ligands with DNA-Targeting Ability
  33. Interactions between Anticancer trans-Platinum Compounds and Proteins: Crystal Structures and ESI-MS Spectra of Two Protein Adducts of trans-(Dimethylamino)(methylamino)dichloridoplatinum(II)
  34. Peculiar Features in the Crystal Structure of the Adduct Formed betweencis-PtI2(NH3)2and Hen Egg White Lysozyme
  35. The second generation of iodido complexes: trans-[PtI2(amine)(amine′)] bearing different aliphatic amines
  36. anticancer non traditional drugs
  37. Novel clioquinol and its analogous platinum complexes: importance, role of the halogen substitution and the hydroxyl group of the ligand
  38. Understanding trans platinum complexes as potential antitumor drugs beyond targeting DNA
  39. Reactivity and Biological Properties of a Series of Cytotoxic PtI2(amine)2 Complexes, Either cis or trans Configured
  40. Non-Classical Structures Among Current Platinum Complexes with Potential as Antitumor Drugs
  41. Synthesis, characterization and tumor cell growth inhibition of new trans platinum complexes with phosphane derivatives
  42. The preparation and characterization of trans-platinum(iv) complexes with unusually high cytotoxicity
  43. Experimental Validation of the Predictions of a Mathematical Model for Protein Purification and Tag Selection
  44. Photoactivation of trans diamine platinum complexes in aqueous solution and effect on reactivity towards nucleotides
  45. Cytotoxic Profile and Peculiar Reactivity with Biomolecules of a Novel “Rule-Breaker” Iodidoplatinum(II) Complex
  46. Proteins as Possible Targets for Cytotoxic trans-Platinum(II) Complexes with Aliphatic Amine Ligands: Further Exceptions to the DNA Paradigm
  47. ChemInform Abstract: Synthesis, Cytotoxic Activities and Proposed Mode of Binding of a Series of Bis{[(9-oxo-9,10-dihydroacridine-4-carbonyl)amino]alkyl}alkylamines.
  48. An androgenic steroid delivery vector that imparts activity to a non-conventional platinum(ii) metallo-drug
  49. Conjugation of testosterone modifies the interaction of mono-functional cationic platinum(ii) complexes with DNA, causing significant alterations to the DNA helix
  50. New reactions of anticancer-platinum complexes and their intriguing behaviour under various experimental conditions
  51. The role of p53 in the cellular toxicity by active trans-platinum complexes containing isopropylamine and hydroxymethylpyridine
  52. Solution Behaviour and Biomolecular Interactions of Two Cytotoxictrans-Platinum(II) Complexes Bearing Aliphatic Amine Ligands
  53. Inhibition of p38-MAPK Potentiates Cisplatin-Induced Apoptosis via GSH Depletion and Increases Intracellular Drug Accumulation in Growth-Arrested Kidney Tubular Epithelial Cells
  54. [1H,15N] NMR studies of the aquation of cis-diamine platinum(II) complexes
  55. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(ii) anticancer complexes
  56. Influence of (Hydroxymethyl)pyridine and Pyridine-carboxylic Acids, intrans-Position to the Isopropylamine and Ammine Ligands, on the Cytotoxicity of Platinum Complexes
  57. Platinum(IV) Complexes of 3‐ and 4‐Picolinic Acids Containing Ammine or Isopropylamine Ligands – Synthesis, Characteri­zation, X‐ray Structures, and Evaluation of Their Cytotoxic Activity against Cancer Cell Lines
  58. Isolation of an Intermediate in the Platination of p ‐Nitroacetophenone 4‐Methylthiosemicarbazone: Potential Application as an Antitumor Drug
  59. Isolation of an Intermediate in the Platination ofp-Nitroacetophenone 4-Methylthiosemicarbazone: Potential Application as an Antitumor Drug (Eur. J. Inorg. Chem. 8/2008)
  60. New trans-Platinum Drugs with Phosphines and Amines as Carrier Ligands Induce Apoptosis in Tumor Cells Resistant to Cisplatin
  61. Trans platinum complexes design: One novel water soluble oxime derivative that contains aliphatic amines in trans configuration
  62. Structural Characterization, DNA Interactions, and Cytotoxicity of New Transplatin Analogues Containing One Aliphatic and One Planar Heterocyclic Amine Ligand
  63. Novel Transplatinum(II) Complexes with [N2O2] Donor Sets. Cellular Pharmacology and Apoptosis Induction in Pam 212-ras Cells
  64. Pyridine-Carboxylate Complexes of Platinum. Effect of N,O-Chelate Formation on Model Bifunctional DNA−DNA and DNA−Protein Interactions
  65. Contribution to the SAR field of metallated and coordination complexes
  66. Preparation, characterization and cytotoxic activity of new compounds trans-[PtCl2NH3(3-(hydroxymethyl)-pyridine)] and trans-[PtCl2NH3(4-(hydroxymethyl)-pyridine)]
  67. Synthesis and Characterization of New Transplatinum Complexes Containing Phosphane Groups − Cytotoxic Studies in Cisplatin‐Resistant Cells
  68. Orientation‐ and Temperature‐Dependent Rotational Behavior of Imidazole Ligands (L) in β‐[Ru(azpy) 2 (L) 2 ](PF 6 ) 2 ...
  69. Determination of catalase activity in samples treated with [ZnCl2(isopropylamine)2]: a novel zinc complex that slows down the decay in activity of catalase extracts
  70. Synthesis, cytotoxic activities and proposed mode of binding of a series of bis{[(9-oxo-9,10-dihydroacridine-4-carbonyl)amino]alkyl}alkylamines
  71. Cellular Uptake, DNA Binding and Apoptosis Induction of CytotoxicTrans‐[PtCl2(N,N‐dimethylamine)(Isopropylamine)] in A2780cisROvarian Tumor Cells
  72. Synthesis and characterization of Pd(II) and Pt(II) complexes of -isopropylbenzaldehyde N-protected thiosemicarbazones. Cytotoxic activity against -transformed cells
  73. A cycloplatinated compound of p-isopropylbenzaldehyde thiosemicarbazone and its chloro-bridged derivative induce apoptosis in cis-DDP resistant cells which overexpress the H-ras oncogene
  74. Synthesis, characterization and DNA modification induced by a novel Pt(IV)-bis(monoglutarate) complex which induces apoptosis in glioma cells
  75. DNA binding and in vitro antileukemic activity of dimeric and tetrameric platinated complexes derived from p‐isopropylbenzaldehyde thiosemicarbazone
  76. Palladated and platinated complexes derived from phenylacetaldehyde thiosemicarbazone with cytotoxic activity in cis-DDP resistant tumor cells. Formation of DNA interstrand cross-links by these complexes
  77. Novel Tetranuclear Orthometalated Complexes of Pd(II) and Pt(II) Derived from p-Isopropylbenzaldehyde Thiosemicarbazone with Cytotoxic Activity in cis-DDP Resistant Tumor Cell Lines. Interaction of These Complexes with DNA
  78. Binuclear chloro-bridged palladated and platinated complexes derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxicity against cisplatin resistant tumor cell lines